SEDELLE HENDERSON-BAMIDELE: Open Payments
NPI 1407395759 · BEAR, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 14 payments from 9 companies in 2025. Trend: 2023 $3,555 · 2024 $979 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 3 | $351 |
| Ardelyx, Inc. | 3 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| Fresenius USA Marketing, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $21 |
Products named: Vafseo, XPHOZAH 30 MG, DRIZALMA SPRINKLE, AUSTEDO XR, Natroba, JARDIANCE, NUCALA, VELPHORO.
Industry payments across DE — which companies pay providers there.
